Joseph P. Erinjeri

HER kinase inhibition in patients with HER2- and HER3-mutant cancers

David M. Hyman, Sarina A. Piha‐Paul, Helen Won et al. · Nature · 2018 · 783 citations

Medicine, Cancer Biology, Oncology +14

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

Richard D. Carvajal, Jeffrey A. Sosman, J. Fernando Quevedo et al. · JAMA · 2014 · 429 citations · Full text

Medicine, Oncology, Pharmacology +15

Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

Eli L. Diamond, Vivek Subbiah, A. Craig Lockhart et al. · JAMA Oncology · 2017 · 405 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

Karen T. Brown, Mithat Gönen, Anne M. Covey et al. · Journal of Clinical Oncology · 2016 · 377 citations · Full text

Medicine, Oncology, Surgery +14

Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes—A 10-year Experience at a Single Center

Waleed Shady, Elena N. Petre, Mithat Gönen et al. · Radiology · 2015 · 370 citations

Medicine, Oncology, Surgery +17